By Yadarisa Shabong (Reuters) -Aston Martin posted a bigger-than-expected first-quarter pretax loss on Wednesday as the British luxury carmaker made fewer cars and burned more cash than analysts anticipated, sending its shares 7% lower. Aston Martin, which has launched several new cars over the past year including its next generation sports cars the DB12 and …
Aston Martin losses balloon ahead of new model ramp up Read More »
LONDON (Reuters) – British manufacturing fell back into contraction in April and cost pressures escalated, although the pace of decline was a little less marked than first feared, a survey showed on Wednesday. The S&P Global UK Manufacturing Purchasing Managers’ Index (PMI) fell in April to 49.1. While higher than a preliminary “flash” estimate of …
UK factories slip back into downturn as cost pressures rise, PMI shows Read More »
By Prerna Bedi (Reuters) -British medical equipment maker Smith+Nephew retained its annual revenue and margin forecasts on Wednesday after posting a near 3% rise in revenue in the first quarter. The group forecast revenue to grow between 5% and 6% this year with a trading margin of 18%, against analysts’ expectations for revenue growth of …
UK’s Smith+Nephew retains forecast for 5-6% revenue growth this year Read More »
By Francesco Canepa and John O’Donnell LONDON (Reuters) -Austrian authorities have urged Raiffeisen Bank International (RBI) to drop a deal linked to a Russian oligarch fearing a backlash from the United States, people familiar with the matter said, a blow to RBI’s plans to unlock funds stranded in Russia. RBI, the biggest Western bank in …
Exclusive-Austrian officials warn Raiffeisen off Russian oligarch deal, sources say Read More »
(Reuters) -Consumer healthcare company Haleon reported first-quarter revenue slightly below market estimates on Wednesday, as volumes declined due to retailer destocking in U.S. and cooling demand for some of its medicines after a surge last year. The maker of popular household products such as Sensodyne toothpaste and pain-reliever Panadol, had earlier said that the first …
Sensodyne-maker Haleon posts tepid sales as demand for some products cool off Read More »
(Fixes headline) By Anne Kauranen, Joanna Plucinska and James Pearson HELSINKI/LONDON (Reuters) -Estonia has accused neighbouring Russia of jamming GPS navigation devices in airspace above the Baltic states, echoing concerns from airlines that say they have been contending with such interference for months. Estonian Foreign Minister Margus Tsahkna’s accusation, for which he provided no proof, …
What is GPS jamming and why is it a problem for aviation? Read More »
(Reuters) – The CEO of German container shipper Hapag-Lloyd said on Monday he expects that the Red Sea crisis can be overcome before the end of the year. Ship operators face prolonged disruption as Yemen-based Houthi militants attack vessels travelling on one of the world’s busiest routes, causing costly redirections around Africa. “It is my …
Hapag Lloyd CEO says he expects Red Sea crisis to end this year Read More »
By Pranav Kashyap, Sruthi Shankar and Khushi Singh (Reuters) -Britain’s FTSE 100 extended its record rally for the fifth straight session on Monday, helped by positive corporate updates, while a stronger pound boosted midcaps. The mid-cap FTSE 250 advanced 1.3%, after touching highest levels in over thirteen months, and taking support from a rise in …
BERLIN (Reuters) – The U.S. Department of Justice has closed its probe into the Mercedes-Benz diesel emissions scandal and the car manufacturer is no longer facing charges, the company said on Saturday. Mercedes-Benz cooperated fully with the DOJ, Renata Jungo Bruengger, board member for integrity, governance and sustainability at Mercedes, said in an emailed statement. …
Mercedes-Benz says US DOJ ended investigation into diesel emissions scandal Read More »
BERLIN (Reuters) – Morphosys said its takeover by Novartis was still expected to be closed in the first half of this year, in a statement responding to a possible safety risk reported by specialist news website STAT News that knocked the company’s share price on Monday. “The planned acquisition by Novartis is progressing steadily,” a …
Morphosys says Novartis takeover progressing as planned for H1 2024 Read More »
